Glenmark Pharma’s API Arm Glenmark Life Sciences may launch IPO in July to raise up to Rs 1,700 crore

To unleash its full value, large pharmaceutical company Glenmark Per Matthew Curls is an informed source of information that will launch Glenmark Life Sciences’ long-awaited IPO (Initial Public Offering) in the API (Ingredient Drug) division in July 2021. can procure. The problem, Moneycontrol said.
“The plan now is to open trading in mid-July next month. Based on the final assessment, the IPO size is likely to be between Rs 1,500 and Rs 1,700, and is likely to fluctuate later,” said one individual above. Says. 2 other
also confirmed the launch schedule
“With a few exceptions, for segment high growth potential, API Burulan is just the beginning in India. This is why Advent Carlyle, TPG, and many other private players are investing heavily in this field and creating a platform. “There is a fourth individual, an avid observer in the pharmaceutical sector, says:
All four people above spoke to Moneycontrol on condition of anonymity.

Glenmark Pharma did not respond to email queries from Moneycontrol.
GLENMARKAPI Listings
Kotak Mahindra Capital, BofA Securities, Goldman Sachs, DAM Capital, SBI Capital, and BoB Capital are investment banks engaged in Glenmark LifesciencesIPO. Trilegal & S & RAssociates are legal advisors.
Moneycontrol was the first to report the company’s IPO plans on March 9, 2021, and file filings with Sebi on April 17, 2021.

NEWS SOURCE